Clinical Trials Browser

Microsatellite Instability × pembrolizumab × 90 days × Clear all

NCT06004245 2026-05-08

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability